The objectives are to study the role of antibodies to melanocytes in the pathogenesis of vitiligo and to determine whether the immune abnormalities present in vitiligo can be harnessed to treat melanoma. We have demonstrated that the majority of patients with vitiligo have antibodies to surface antigens on normal human melanocytes. We now wish to elucidate the role of these antibodies in the pathogenesis of vitiligo by addressing three broad questions: 1) What is the nature of the pigment cell antigens which induce immune responses to melanocytes in vitiligo, 2) Are pigment cell antibodies directly involved in the pathogenesis of vitiligo, as would be evidenced by their ability to damage pigmented cells in vitro, by a relationship between their titer and the activity of the disease, by their appearance before rather than after the onset of vitiligo, and by their ability to induce the disease in actively or passively immunized animals, 3) Are there immunological relationships between melanoma and vitiligo and can these be harnessed to treat this cancer? The results of these studies should define whether or not vitiligo is an autoimmune disease to melanocytes. If that is the case, it could lead to improved methods of treating and perhaps preventing the disease, as well as to novel methods of treating malignant melanoma.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
2R01AR027663-07
Application #
3155545
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1980-12-01
Project End
1991-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
7
Fiscal Year
1987
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Ioannides, D; Golden, B D; Buyon, J P et al. (2000) Expression of SS-A/Ro and SS-B/La antigens in skin biopsy specimens of patients with photosensitive forms of lupus erythematosus. Arch Dermatol 136:340-6
Xie, Z; Chen, D; Jiao, D et al. (1999) Vitiligo antibodies are not directed to tyrosinase. Arch Dermatol 135:417-22
Bystryn, J C (1997) Immune mechanisms in vitiligo. Clin Dermatol 15:853-61
Cui, J; Arita, Y; Bystryn, J C (1995) Characterization of vitiligo antigens. Pigment Cell Res 8:53-9
Tobin, D J; Colen, S R; Bystryn, J C (1995) Isolation and long-term culture of human hair-follicle melanocytes. J Invest Dermatol 104:86-9
Tobin, D J; Orentreich, N; Bystryn, J C (1994) Autoantibodies to hair follicles in normal individuals. Arch Dermatol 130:395-6
Tobin, D J; Orentreich, N; Fenton, D A et al. (1994) Antibodies to hair follicles in alopecia areata. J Invest Dermatol 102:721-4
Ioannides, D; Bystryn, J C (1993) Association of tissue-fixed cytoplasmic deposits of immunoglobulin in epidermal keratinocytes with lupus erythematosus. Arch Dermatol 129:1130-5
Niimi, Y; Zhu, X J; Bystryn, J C (1992) Identification of cicatricial pemphigoid antigens. Arch Dermatol 128:54-7
Cui, J; Harning, R; Henn, M et al. (1992) Identification of pigment cell antigens defined by vitiligo antibodies. J Invest Dermatol 98:162-5

Showing the most recent 10 out of 13 publications